PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS SUITABLE FOR TREATING PULMONARY HYPERTENSION CAUSED BY NEUTRALIZATION BY HEPARIN PROTEMIN, AND COMPRISING 7-OXABICYCLO/2.2.1/-5-HEPTANOIC ACID DERIVATIVE AS ACTIVE INGREDIENT

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.

Saved in:
Bibliographic Details
Main Authors FRIEDHOFF,LAWRENCE T.,US, GROVER,GARY J.,US, OGLETREE,MARTIN L.,US, SCHUMACHER,WILLIAM A.,US
Format Patent
LanguageEnglish
Published 28.10.1992
Edition5
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.
Bibliography:Application Number: HU19890001710